Company / Return on Assets (ROA)
Medpace Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
22.8%
FY2025
5-year range
10.8% / 22.8%
FY2021-FY2025
Trend
+18.6%
vs FY2024
Sector context
#3 of 159
Health Care
What the data says
Among 159 Health Care companies, Medpace is in the top 2% for return on assets (roa). Return on Assets (ROA) has increased for 3 consecutive years, from 10.8% in FY2022 to 22.8% in FY2025.
Based on SEC 10-K filings.
22.8% in FY2025 with a 5-year CAGR of +12.4%. Ranks 3rd among 159 companies in Health Care.
Improved from 17.1% to 22.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +12.1pp
- 5-Year Change
- +12.4pp
- 10-Year Change
- -
Sector benchmark
Top 2% in Health CareTop 2% of 159This company 22.8% Sector average -2.2%
▼
+1132.6% above sector average
Key checks
Key Insights
- Medpace's return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 18.6% year-over-year.
- Currently 25.1pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 22.8% | +18.6% |
| FY2024 | 19.3% | +12.8% |
| FY2023 | 17.1% | +58.8% |
| FY2022 | 10.8% | -1.9% |
| FY2021 | 11.0% | +4.9% |
| FY2020 | 10.4% | +4.5% |
| FY2019 | 10.0% | +619.4% |
| FY2018 | 1.4% | -66.2% |
| FY2017 | 4.1% | +200.0% |
| FY2016 | 1.4% | +255.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026